As I said, I don't believe The Economist is accurate on this point, with the knowledge we have here in Canada relating to the deliveries and procurements I have mentioned here today.
In particular, we are going to see a very rapid ramp-up over the next weeks and months from approved vaccine suppliers alone. As a result, all Canadians who wish to have access will have access prior to the end of September. That is based just on approved vaccines alone, but we know we have others in rolling review.
This is the benefit of having a diversified portfolio. We—